News Headlines Article

Lower HIV drug prices for state programs, protestors ask Gilead
San Francisco Business Times

HIV patient advocates protested outside and inside Gilead Sciences Inc.’s annual shareholder meeting Thursday, pleading for the world’s largest AIDS drug developer to cut the prices it charges cash-strapped government safety net programs. About 20 people protested outside the Westin San Francisco Airport hotel, saying that the Foster City-based company (NASDAQ: GILD) could take a haircut on the $10,000 price it charges state AIDS drug assistance programs, or ADAPs.

Commands